Apple
- Collected applications
- 1,559
- Share of collected applications with IPC
- 14.2%
Coverage is incomplete; counts and shares describe only the collected subset.
View Apple publications in this fieldCompany patentsCompare
HEAD TO HEAD
AppleEli LillyICBC
Technology portfolios compared in the same window and counting units. Scale is compared only within the same field or subclass.
+ Agricultural Bank of China2025-01 — 2025-12+ Alibaba2025-01 — 2025-12+ Alphabet (Google)2025-01 — 2025-12+ Amazon2025-01 — 2025-12✓ Apple2025-01 — 2025-12+ Bank of China2025-01 — 2025-12+ BOE2024-01 — 2024-12+ Broadcom2025-01 — 2025-12+ BYD2024-01 — 2024-12+ CATL2024-01 — 2024-12+ China Construction Bank2025-01 — 2025-12+ China Mobile2025-01 — 2025-12+ CXMT2025-01 — 2025-12✓ Eli Lilly2025-01 — 2025-12+ Huawei2024-01 — 2024-12✓ ICBC2025-01 — 2025-12+ Meta2025-01 — 2025-12+ Microsoft2025-01 — 2025-12+ Midea2024-01 — 2024-12+ Kweichow Moutai2025-01 — 2025-12+ NVIDIA2025-01 — 2025-12+ PetroChina2025-01 — 2025-12+ SpaceX2025-01 — 2025-12+ Tencent2025-01 — 2025-12+ Tesla2025-01 — 2025-12
Same window · published 2025-01-01 — 2025-12-31Some name or date coverage is incomplete; affected counts are lower bounds
This is a structural comparison of collected portfolios. The same requested window does not establish equal entity scope, covered months or industry; no competitive ranking is inferred.
Applicant-name coverage differs. The counts below cover only the listed names and do not represent complete company portfolios.
Apple: Applicant names included in these statistics — APPLE INCReviewed names not covered — APPLE COMPUTER INC · APPLE COMPUTER, INC. · APPLE INC. · APPLE, INC.
Eli Lilly: Applicant names included in these statistics — ELI LILLY AND CO · ELI LILLY AND COMPANY USA · LILLY CO ELIReviewed names not covered — ELI LILLY AND COMPANY
ICBC: Applicant names included in these statistics — INDUSTRIAL & COMMERCIAL BANK OF CHINA CO LTDReviewed names not covered — INDUSTRIAL AND COMMERCIAL BANK OF CHINA LIMITED · 中国工商银行股份有限公司
Apple
- Publications
- 12,360
- Invention share
- 87%
- Concentration
- 0.38
- Green technology
- —
Eli Lilly
- Publications
- 1,602
- Invention share
- 45%
- Concentration
- 0.73
- Green technology
- —
ICBC
- Publications
- 3,242
- Invention share
- 100%
- Concentration
- 0.81
- Green technology
- —
0.02
Apple × Eli Lilly
0.69
Apple × ICBC
0.01
Eli Lilly × ICBC
01Technology field mirror
The 12 fields with the largest combined share. Share shows structure; count shows scale.
| Technology field | Apple / Eli Lilly / ICBC |
|---|---|
| Computer technology | 39.1% 0.6% 78.6% |
| Pharmaceuticals | 0% 68.5% 0% |
| Digital communication | 42.1% 0.1% 15.6% |
| IT methods for management | 2.4% 0.2% 41.3% |
| Biotechnology | 0% 39.9% 0% |
| Organic fine chemistry | 0% 25.8% 0% |
| Medical technology | 2.6% 17.6% 0.1% |
| Audio-visual technology | 14.2% 0.1% 1% |
| Telecommunications | 13.9% 0% 0.8% |
| Optics | 7.2% 0% 0% |
| Measurement | 5.7% 1% 0.3% |
| Electrical machinery, apparatus, energy | 4.8% 0% 0.2% |
Inspect one technology field
Inspect collected applications, portfolio share and supporting publications within one field. A technology overlap does not establish that companies in different industries are direct competitors.
Eli Lilly
- Collected applications
- 1
- Share of collected applications with IPC
- 0.1%
Coverage is incomplete; counts and shares describe only the collected subset.
View Eli Lilly publications in this fieldICBC
- Collected applications
- 33
- Share of collected applications with IPC
- 1%
Coverage is incomplete; counts and shares describe only the collected subset.
View ICBC publications in this fieldOne application may belong to multiple fields, so shares can sum to more than 100%. Drill-down lists publications; an application publication and its grant may appear separately.
02Same problem: shared IPC subclasses
The 10 subclasses in every company's top 60 with the most combined applications. Scale is compared within a subclass, never across different business scopes.
G06FData processing
Apple3,635
Eli Lilly2
ICBC2,203
H04WWireless networks
Apple3,570
Eli Lilly2
ICBC42
G06QBusiness data processing
Apple264
Eli Lilly3
ICBC1,339
G06TImage processing
Apple986
Eli Lilly5
ICBC74
G06NComputing models, AI
Apple200
Eli Lilly3
ICBC829
G06VImage and video recognition
Apple417
Eli Lilly2
ICBC259
A61BMedical diagnosis
Apple194
Eli Lilly36
ICBC1
G16H
Apple123
Eli Lilly36
ICBC3
G08B
Apple72
Eli Lilly5
ICBC10
G01RMeasuring electric variables
Apple61
Eli Lilly3
ICBC4
03Where each one leans
Observed emphasis within each company’s collected top-60 IPC subclasses. A dash for another company means outside its top-60 list, not zero applications or a market gap. Incomplete coverage can also change the ordering.
Apple
- H04WWireless networks
- Apple
- 3,570
- Eli Lilly
- 2
- ICBC
- 42
- H04BTransmission
- Apple
- 981
- Eli Lilly
- —
- ICBC
- 2
- H04NPictorial communication, video
- Apple
- 931
- Eli Lilly
- —
- ICBC
- 26
- G06TImage processing
- Apple
- 986
- Eli Lilly
- 5
- ICBC
- 74
- G02BOptical elements
- Apple
- 679
- Eli Lilly
- —
- ICBC
- —
- H04LDigital transmission
- Apple
- 2,146
- Eli Lilly
- —
- ICBC
- 468
Eli Lilly
- A61K
- Apple
- —
- Eli Lilly
- 926
- ICBC
- —
- A61P
- Apple
- —
- Eli Lilly
- 766
- ICBC
- —
- C07K
- Apple
- —
- Eli Lilly
- 454
- ICBC
- —
- C07DHeterocyclic compounds
- Apple
- —
- Eli Lilly
- 300
- ICBC
- —
- A61M
- Apple
- —
- Eli Lilly
- 196
- ICBC
- —
- C12NMicroorganisms, enzymes
- Apple
- —
- Eli Lilly
- 153
- ICBC
- —
ICBC
- G06QBusiness data processing
- Apple
- 264
- Eli Lilly
- 3
- ICBC
- 1,339
- G06FData processing
- Apple
- 3,635
- Eli Lilly
- 2
- ICBC
- 2,203
- G06NComputing models, AI
- Apple
- 200
- Eli Lilly
- 3
- ICBC
- 829
- G06VImage and video recognition
- Apple
- 417
- Eli Lilly
- 2
- ICBC
- 259
- G07F
- Apple
- —
- Eli Lilly
- —
- ICBC
- 17
- G07C
- Apple
- —
- Eli Lilly
- —
- ICBC
- 14
04Publication rhythm
| Period | Apple | Eli Lilly | ICBC |
|---|---|---|---|
| 2025-01 | ≥1,049 (partial coverage) | ≥118 (partial coverage) | ≥136 (partial coverage) |
| 2025-02 | ≥968 (partial coverage) | ≥121 (partial coverage) | ≥70 (partial coverage) |
| 2025-03 | ≥1,319 (partial coverage) | ≥158 (partial coverage) | ≥497 (partial coverage) |
| 2025-04 | ≥1,232 (partial coverage) | ≥110 (partial coverage) | ≥497 (partial coverage) |
| 2025-05 | ≥993 (partial coverage) | ≥134 (partial coverage) | ≥231 (partial coverage) |
| 2025-06 | ≥846 (partial coverage) | ≥140 (partial coverage) | ≥75 (partial coverage) |
| 2025-07 | ≥956 (partial coverage) | ≥138 (partial coverage) | ≥85 (partial coverage) |
| 2025-08 | ≥989 (partial coverage) | ≥134 (partial coverage) | ≥127 (partial coverage) |
| 2025-09 | ≥906 (partial coverage) | ≥132 (partial coverage) | ≥385 (partial coverage) |
| 2025-10 | ≥928 (partial coverage) | ≥155 (partial coverage) | ≥284 (partial coverage) |
| 2025-11 | ≥1,005 (partial coverage) | ≥140 (partial coverage) | ≥427 (partial coverage) |
| 2025-12 | ≥1,169 (partial coverage) | ≥122 (partial coverage) | ≥428 (partial coverage) |
Empty dashed outlines mark uncollected periods. Hatched bars and ≥ counts mark partial coverage.
Publication timing follows examination and publication cycles, not R&D intensity.
What makes it comparableThe same publication window and counting units. Companies with different windows are not put in one comparison.
What is not comparableGroup totals. Business and entity scopes differ; compare scale within a field or subclass.
Not a rankingSimilarity and shares describe structure, not patent value, quality or technical leadership.